Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI
about
The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and ChallengesNeural differentiation from pluripotent stem cells: The role of natural and synthetic extracellular matrixSustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injuryIntramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction.Dynamic behaviors of astrocytes in chemically modified fibrin and collagen hydrogels.The effects of controlled release of neurotrophin-3 from PCLA scaffolds on the survival and neuronal differentiation of transplanted neural stem cells in a rat spinal cord injury model.Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.Rodent Models and Behavioral Outcomes of Cervical Spinal Cord Injury.Survival, Differentiation, and Migration of High-Purity Mouse Embryonic Stem Cell-derived Progenitor Motor Neurons in Fibrin Scaffolds after Sub-Acute Spinal Cord InjuryRepair of injured spinal cord using biomaterial scaffolds and stem cells.Neural tissue engineering using embryonic and induced pluripotent stem cells.In vitro selection technologies to enhance biomaterial functionality.Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation.A puromycin selectable cell line for the enrichment of mouse embryonic stem cell-derived V3 interneuronsCombination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury.Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia.Combining adult stem cells and olfactory ensheathing cells: the secretome effect.Endometriotic Epithelial Cell Response to Macrophage-Secreted Factors is Dependent on Extracellular Matrix Context.Collagen microsphere serving as a cell carrier supports oligodendrocyte progenitor cell growth and differentiation for neurite myelination in vitro.Sculpting the blank slate: how fibrin's support of vascularization can inspire biomaterial designTissue engineered constructs for peripheral nerve surgery.Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug/gene delivery to direct axon regeneration in spinal cord injury treatment.Neurotransplantation: lux et veritas, fiction or reality?Combination therapies in the CNS: engineering the environment.Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues.Regenerative medicine for the treatment of spinal cord injury: more than just promises?Current concepts and advances in the application of tissue engineering in otorhinolaryngology and head and neck surgery.Regenerative therapies for central nervous system diseases: a biomaterials approach.Extracellular matrices, artificial neural scaffolds and the promise of neural regeneration.Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation.Combinatorial Therapies After Spinal Cord Injury: How Can Biomaterials Help?Design of Injectable Materials to Improve Stem Cell Transplantation.Combination scaffolds of salmon fibrin, hyaluronic acid, and laminin for human neural stem cell and vascular tissue engineering.Stem cell therapy for white matter disorders: don't forget the microenvironment!Functional Test Scales for Evaluating Cell-Based Therapies in Animal Models of Spinal Cord Injury.Covalent growth factor tethering to direct neural stem cell differentiation and self-organization.Enhancing neuronal growth from human endometrial stem cells derived neuron-like cells in three-dimensional fibrin gel for nerve tissue engineering.Combined use of spinal cord-mimicking partition type scaffold architecture and neurotrophin-3 for surgical repair of completely transected spinal cord in rats.Engineering personalized neural tissue by combining induced pluripotent stem cells with fibrin scaffolds.Adipose-Derived Mesenchymal Stem Cell Application Combined With Fibrin Matrix Promotes Structural and Functional Recovery Following Spinal Cord Injury in Rats.
P2860
Q26860309-FEE06A53-1E1B-47A6-8700-FD3107801D2FQ27007542-FD242644-D884-428A-B817-1C2D518D98EFQ28603502-76E8D45D-A4EB-422A-980D-685617A68701Q30536488-6A5E37FD-351E-4F0F-BF66-DCB0317C9BCBQ30757657-0877AF6C-0A8C-4A7D-817F-D095C12194CDQ34172601-E5E29B4D-8C45-473A-BA11-167C127D7671Q34172960-7CEA652B-0EF8-468F-9FB2-17D0A73E8E75Q34314659-14A50D74-98CB-49CE-8108-E4EBD29C2F1EQ34385981-D741D5D2-7B30-4C28-9576-F49212EBC089Q34803857-632A0C66-6CB6-4658-B424-A315198A4657Q35579271-7B24CEFF-A389-4BAD-A085-69E716D32263Q36020230-199FF25A-EE43-49CB-A905-196E70FCEAF9Q36222105-ED20F7A4-181B-4D0A-9554-D1DC92F2BFB8Q36270578-21D32925-5964-4D0A-AB0A-4E0F19EC2817Q36289089-B49ADA41-BDBB-48D3-824A-1568C1DEDD54Q36464568-77CF4E68-ECA3-4550-958C-B69B10F5B7F5Q36733764-5CE701C9-3D95-4304-BE27-CCB7D97F6D74Q37078253-53A5E9DB-8345-4828-A44F-5258E753F770Q37372541-7740ADFD-8D55-4AC8-98F1-55F25BBEF5D4Q37394744-EB68EBA4-B2B0-499C-B157-FC52F617EFEEQ37419334-E4D8243B-B76D-43F5-AEC7-2CEF305E06E6Q37627866-DE7B3E53-DB5E-4D54-960E-78C48E4B0E7EQ37971309-ED0E7523-C418-4EB2-867B-AAAB6C4E9E19Q37985448-FF4FC2E6-31EB-423C-BFD0-E10AFA5A1FCFQ37998022-A25DC87C-E7BE-4EB9-A8F4-993F04CB5A36Q38026986-6B9AA3B0-F8C1-4CA7-8991-02F9D0C514ABQ38065427-409DC477-F90F-473C-949C-E5C6302E2039Q38133954-CA815993-4F7E-46AA-9781-5EEC59042FBCQ38264907-E4E035E0-D860-4FBF-9BF1-4787F5DAF03AQ38929153-5883A1BD-9E06-4510-BDDF-538984563C56Q39155863-2E3A8F8D-511C-4176-B185-7D642038245CQ41560335-1F9B29CF-1A4F-4037-ABC3-543B6C3C15C2Q41628071-820B2DB1-64BD-4208-B93D-0A80DE6CCC29Q42009902-5EBFD846-D068-496F-8D8C-251320A0801EQ44581554-01727DB9-66FA-4D7B-AE72-023AA9A484EAQ47346648-AB07AC87-ECD5-4CAE-A4DA-F6B40ED32CB8Q47733770-9837F808-3A9B-4BCF-B8BE-DE65AACB774BQ51017278-DC065D88-67F4-494E-8C09-C673079442D2Q51831198-446914DE-3A64-4461-9736-64812A0D1160Q53402448-D5864A81-9044-47A9-A000-B8167B1626C8
P2860
Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@ast
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@en
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@nl
type
label
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@ast
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@en
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@nl
prefLabel
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@ast
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@en
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@nl
P2093
P2860
P356
P1433
P1476
Tissue-engineered fibrin scaff ...... ery in a subacute model of SCI
@en
P2093
Alexander Tatara
Alicia Shiu
Dylan A McCreedy
Shelly E Sakiyama-Elbert
P2860
P304
P356
10.1039/C0SM00173B
P577
2010-10-01T00:00:00Z